Premature Menopause Can Lead to Mental Decline: Study

Friday, 09 May 2014 03:52 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
Premature menopause may increase a woman's risk of mental decline later in life, according to a new study.

Compared to those who began menopause after age 50, women with premature menopause were 40 percent more likely to do poorly on verbal and visual memory tests, the study found.

They also had a 35 percent higher risk of decline in psychomotor speed (coordination between the brain and the muscles that brings about movement) and overall mental function.

Menopause typically occurs at about age 50, but can begin between ages 41 and 45 (early menopause) or at or around age 40 (premature menopause). Early and premature menopause can occur naturally or be caused by surgical removal of the ovaries.

Special: 4 Easy Ways to Keep Your Mind Sharp

Of the more than 4,800 women in the study, nearly 8 percent had premature menopause. All of the participants underwent mental skills tests at the start of the study and again two, four and seven years later.

There was no significant association between premature menopause and increased risk of dementia, according to the study published May 7 in BJOG: An International Journal of Obstetrics and Gynaecology.

There was some evidence that using hormone treatment at the time of premature menopause might benefit visual memory, but could also increase the risk of verbal problems, according to Dr. Joanne Ryan, of Hospital La Colombiere in Montpellier, France.

"With the aging population, it is important to have a better understanding of the long term effects of a premature menopause on later-life cognitive function and the potential benefit from using menopausal hormone treatment," Pierre Martin Hirsch, BJOG deputy editor-in-chief, said in a journal news release.

"This study adds to the existing evidence base to suggest premature menopause can have a significant impact on cognitive function in later life, which healthcare professionals must be aware of," he added.

© HealthDay

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Is Ebola Here? Texas Patient Tested

Tuesday, 30 Sep 2014 11:19 AM

A patient with symptoms of Ebola has been placed in strict isolation at a Texas hospital, and test results are expected  . . .

Cancer Immune Drugs Come of Age Amid Cost Concerns

Tuesday, 30 Sep 2014 09:25 AM

A raft of newcancer drugs promise better, longer-lasting treatments with feweradverse side effects -- but their high cos . . .

Chronic Sinusitis: New Drug Shows Promise

Tuesday, 30 Sep 2014 09:10 AM

An experimental drug from Sanofi and Regeneron significantly reduced congestion in in amid-stage trial on patients with  . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved